School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom; Bristol Heart Institute, Bristol, United Kingdom.
School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.
JACC Cardiovasc Imaging. 2018 May;11(5):686-694. doi: 10.1016/j.jcmg.2017.07.022. Epub 2017 Nov 15.
This study sought to evaluate the prognostic usefulness of visual and quantitative perfusion cardiac magnetic resonance (CMR) ischemic burden in an unselected group of patients and to assess the validity of consensus-based ischemic burden thresholds extrapolated from nuclear studies.
There are limited data on the prognostic value of assessing myocardial ischemic burden by CMR, and there are none using quantitative perfusion analysis.
Patients with suspected coronary artery disease referred for adenosine-stress perfusion CMR were included (n = 395; 70% male; age 58 ± 13 years). The primary endpoint was a composite of cardiovascular death, nonfatal myocardial infarction, aborted sudden death, and revascularization after 90 days. Perfusion scans were assessed visually and with quantitative analysis. Cross-validated Cox regression analysis and net reclassification improvement were used to assess the incremental prognostic value of visual or quantitative perfusion analysis over a baseline clinical model, initially as continuous covariates, then using accepted thresholds of ≥2 segments or ≥10% myocardium.
After a median 460 days (interquartile range: 190 to 869 days) follow-up, 52 patients reached the primary endpoint. At 2 years, the addition of ischemic burden was found to increase prognostic value over a baseline model of age, sex, and late gadolinium enhancement (baseline model area under the curve [AUC]: 0.75; visual AUC: 0.84; quantitative AUC: 0.85). Dichotomized quantitative ischemic burden performed better than visual assessment (net reclassification improvement 0.043 vs. 0.003 against baseline model).
This study was the first to address the prognostic benefit of quantitative analysis of perfusion CMR and to support the use of consensus-based ischemic burden thresholds by perfusion CMR for prognostic evaluation of patients with suspected coronary artery disease. Quantitative analysis provided incremental prognostic value to visual assessment and established risk factors, potentially representing an important step forward in the translation of quantitative CMR perfusion analysis to the clinical setting.
本研究旨在评估视觉和定量灌注心脏磁共振(CMR)缺血负荷在未经选择的患者群体中的预后价值,并评估从核研究推断的基于共识的缺血负荷阈值的有效性。
关于 CMR 评估心肌缺血负荷的预后价值的数据有限,且尚无使用定量灌注分析的研究。
纳入疑似冠心病并接受腺苷应激灌注 CMR 检查的患者(n=395;70%为男性;年龄 58±13 岁)。主要终点为 90 天后心血管死亡、非致死性心肌梗死、猝死未遂和血运重建的复合终点。灌注扫描采用视觉评估和定量分析。交叉验证 Cox 回归分析和净重新分类改善用于评估视觉或定量灌注分析对基线临床模型的增量预后价值,最初作为连续协变量,然后使用公认的≥2 节段或≥10%心肌的阈值。
中位随访 460 天(四分位距:190 至 869 天)后,52 例患者达到主要终点。在 2 年时,发现缺血负荷的增加提高了基于年龄、性别和延迟钆增强的基线模型的预后价值(基线模型曲线下面积[AUC]:0.75;视觉 AUC:0.84;定量 AUC:0.85)。二分定量缺血负荷比视觉评估表现更好(与基线模型相比,净重新分类改善 0.043 对 0.003)。
本研究首次探讨了灌注 CMR 定量分析的预后获益,并支持使用基于共识的缺血负荷阈值进行疑似冠心病患者的预后评估。定量分析为视觉评估和既定危险因素提供了增量预后价值,可能代表了将定量 CMR 灌注分析转化为临床实践的重要一步。